Marlborough, Mass.-based Boston Scientific said the endoscope is designed to provide images of the biliary system in endoscopic retrograde cholangiopancreatography procedures when X-ray imaging isn’t sufficient.
"Early detection is critical to improving outcomes in patients suffering from difficult pancreatico-biliary diseases, such as pancreatic cancer," endoscopy president David Pierce said in prepared remarks. "The new SpyGlass DS system can be performed as an extension of any ERCP procedure, enabling physicians to diagnose and treat more of their patients effectively and efficiently. Boston Scientific is proud to bring single-operator cholangioscopy to a new level of treatment."
Boston Scientific said it 1st launched the SpyGlass device in 2007.
"I’m extremely pleased with the overall functionality of the new SpyGlass DS system," Dr. Robert Hawes of Florida Hospital Orlando added in a statement. "It was quick and easy to set up (‘plug and play’), the image quality and stability excellent and the 4-way tip deflection intuitive. The system now enables endoscopists with ERCP expertise to perform cholangioscopy with or without intervention. My expectation is that this technology will increase our ability to diagnose and treat pancreatobiliary diseases and reduce the number of repeat ERCPs."
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.